Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
New research indicates proportion of young women who have never been screened for cervical cancer more than doubled since 2005
Developed by a British firm, the test will be available as a $29 add-on to pricier genetic profiling assays
Clinical laboratories may soon be able to use a simplified LDL cholesterol calculation
New ACMG recommendations aim to make CFTR carrier detection more equitable among a wider range of ancestries.
Research reveals that diagnostic error in the US may cause up to 800,000 serious outcomes annually.
The agency recently sent its own proposed LDTs regulation rule to the White House Office of Information and Regulatory Affairs for review.
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
A new five-metabolite blood test designed by algorithm could simplify and speed up this challenging diagnosis.
Protein levels in the vitreous humor may have the potential to support the diagnosis and staging of neurodegenerative diseases.
A new assay uses AI-optimized enzymes to simplify and increase the accuracy of rapid pathogen detection.
Accessible screening tests and inclusive management strategies may limit the global cervical cancer incidence rate.
New program aims to provide greater transparency on the recommended performance characteristics of such tests.
Multiorgan analysis of biobank data elucidates heart–brain links that could enhance disease prevention and detection.
